Is Cardiff Oncology, Inc. (CRDF) a Buy, Sell, or Hold?
NASDAQ : CRDF
Cardiff Oncology, Inc.
$0.8903 USD
$0.0 (0.11%)
- Volume
- 1.19M
- Average Volume
- 1.41M
- Market Capitalization
- $60.87M
- P/E Ratio
- -1.33
- Dividend Yield
- 0.00%
- Price Target
- $2.00
- Year High
- $4.56
- Year Low
- $0.83
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $3.27
NUMBER OF INSIDERS BUYING (LAST 12 MONTHS)
19
NUMBER OF INSIDERS SELLING (LAST 12 MONTHS)
0
AMOUNT OF INSIDER SELLING (LAST 12 MONTHS)
-$
CRDF Estimated and Actual Revenue by Quarter
Get MSFT Insider Trade Alerts
CRDF Insider Trading History
| Insider Name | Title | Date | Transaction | Cost | Filing Date |
|---|---|---|---|---|---|
| PACE GARY W | director | 2026-07-14 | P-Purchase | 1.455 | 2026-07-16 |
| PACE GARY W | director | 2026-07-14 | P-Purchase | 1.33 | 2026-07-16 |
| Mohindru Mani | director, officer: Chief Executive Officer | 2026-07-14 | P-Purchase | 1.455 | 2026-07-16 |
| Mohindru Mani | director, officer: Chief Executive Officer | 2026-07-14 | P-Purchase | 1.33 | 2026-07-16 |
| Mohindru Mani | director, officer: Chief Executive Officer | 2026-06-18 | P-Purchase | 1.21 | 2026-06-22 |
| PACE GARY W | director | 2026-06-18 | P-Purchase | 1.22 | 2026-06-22 |
| Armitage James O | director | 2026-06-11 | A-Award | 1.59 | 2026-06-15 |
| White Lale | director | 2026-06-11 | A-Award | 1.59 | 2026-06-15 |
| TANNENBAUM RENEE P | director | 2026-06-11 | A-Award | 1.59 | 2026-06-15 |
| Markin Rodney S | director | 2026-06-11 | A-Award | 1.59 | 2026-06-15 |
| PACE GARY W | director | 2026-06-11 | A-Award | 1.59 | 2026-06-15 |
| Aggarwal Ajay | officer: Chief Operating Officer | 2026-04-27 | A-Award | 1.72 | 2026-04-28 |
| Aggarwal Ajay | 2026-04-27 | 0 | 2026-04-28 | ||
| Muntner Joshua B | officer: Chief Financial Officer | 2026-04-06 | 0 | 2026-04-16 | |
| Smeal Tod | officer: Chief Scientific Officer | 2026-04-14 | A-Award | 1.63 | 2026-04-16 |
| Muntner Joshua B | officer: Chief Financial Officer | 2026-04-06 | A-Award | 1.58 | 2026-04-16 |
| Mohindru Mani | director, officer: Chief Executive Officer | 2026-03-31 | A-Award | 1.62 | 2026-04-02 |
| Lindsay Brigitte Ute | officer: Chief Accounting Officer | 2026-02-13 | A-Award | 1.6 | 2026-02-18 |
| Mohindru Mani | director, officer: Interim CEO | 2026-02-17 | A-Award | 1.56 | 2026-02-18 |
| Lindsay Brigitte Ute | officer: Chief Accounting Officer | 2026-01-27 | 0 | 2026-02-09 | |
| Lindsay Brigitte Ute | officer: Chief Accounting Officer | 2026-01-27 | 1.72 | 2026-02-09 | |
| Lindsay Brigitte Ute | officer: Chief Accounting Officer | 2026-01-27 | 3.51 | 2026-02-09 | |
| Lindsay Brigitte Ute | officer: Chief Accounting Officer | 2026-01-27 | 2.48 | 2026-02-09 | |
| Lindsay Brigitte Ute | officer: Chief Accounting Officer | 2026-01-27 | 21.6 | 2026-02-09 | |
| Lindsay Brigitte Ute | officer: Chief Accounting Officer | 2026-01-27 | 2.5 | 2026-02-09 | |
| Lindsay Brigitte Ute | officer: Chief Accounting Officer | 2026-01-27 | 7.98 | 2026-02-09 | |
| Lindsay Brigitte Ute | officer: Chief Accounting Officer | 2026-01-27 | 2.6 | 2026-02-09 | |
| Lindsay Brigitte Ute | officer: Chief Accounting Officer | 2026-01-27 | 3.58 | 2026-02-09 | |
| PACE GARY W | director | 2025-07-30 | P-Purchase | 2.45 | 2025-07-31 |
| PACE GARY W | director | 2025-07-30 | P-Purchase | 2.45 | 2025-07-31 |
| Sidhu Roger | officer: Chief Medical Officer | 2025-06-16 | 3.86 | 2025-07-08 | |
| TANNENBAUM RENEE P | director | 2025-06-26 | A-Award | 3.16 | 2025-06-30 |
| Markin Rodney S | director | 2025-06-26 | A-Award | 3.16 | 2025-06-30 |
| Mohindru Mani | director | 2025-06-26 | A-Award | 3.16 | 2025-06-30 |
| Armitage James O | director | 2025-06-26 | A-Award | 3.16 | 2025-06-27 |
| White Lale | director | 2025-06-26 | A-Award | 3.16 | 2025-06-27 |
| PACE GARY W | director | 2025-06-26 | A-Award | 3.16 | 2025-06-27 |
| Kabbinavar Fairooz | officer: Chief Medical Officer | 2025-03-11 | A-Award | 3.58 | 2025-03-13 |
| Levine James E. | officer: Chief Financial Officer | 2025-03-11 | A-Award | 3.58 | 2025-03-13 |
| Smeal Tod | officer: Chief Scientific Officer | 2025-03-11 | A-Award | 3.58 | 2025-03-13 |
| Erlander Mark | director, officer: Chief Executive Officer | 2025-03-11 | A-Award | 3.58 | 2025-03-13 |
| Levine James E. | officer: Chief Financial Officer | 2024-12-18 | P-Purchase | 5 | 2024-12-18 |
| Levine James E. | officer: Chief Financial Officer | 2024-12-17 | P-Purchase | 5.4162 | 2024-12-18 |
| Levine James E. | officer: Chief Financial Officer | 2024-12-16 | P-Purchase | 3.83 | 2024-12-18 |
| TANNENBAUM RENEE P | director | 2024-12-12 | P-Purchase | 3.4224 | 2024-12-16 |
| PACE GARY W | director | 2024-12-11 | P-Purchase | 2.6 | 2024-12-12 |
| PACE GARY W | director | 2024-12-11 | P-Purchase | 2.6 | 2024-12-12 |
| White Lale | director | 2024-06-27 | A-Award | 2.33 | 2024-07-01 |
| TANNENBAUM RENEE P | director | 2024-06-27 | A-Award | 2.33 | 2024-07-01 |
| Mohindru Mani | director | 2024-06-27 | A-Award | 2.33 | 2024-07-01 |
| PACE GARY W | director | 2024-06-27 | A-Award | 2.33 | 2024-07-01 |
| Armitage James O | director | 2024-06-27 | A-Award | 2.33 | 2024-07-01 |
| Markin Rodney S | director | 2024-06-27 | A-Award | 2.33 | 2024-07-01 |
| Levine James E. | officer: Chief Financial Officer | 2024-03-07 | A-Award | 3.51 | 2024-03-07 |
| Kabbinavar Fairooz | officer: Chief Medical Officer | 2024-03-07 | A-Award | 3.51 | 2024-03-07 |
| Smeal Tod | officer: Chief Scientific Officer | 2024-03-07 | A-Award | 3.51 | 2024-03-07 |
| Erlander Mark | director, officer: Chief Executive Officer | 2024-03-07 | A-Award | 3.51 | 2024-03-07 |
| PACE GARY W | director | 2023-12-19 | P-Purchase | 1.37 | 2023-12-19 |
| PACE GARY W | director | 2023-11-10 | P-Purchase | 0.98 | 2023-11-14 |
| Markin Rodney S | director | 2023-06-15 | A-Award | 1.59 | 2023-06-20 |
| Armitage James O | director | 2023-06-15 | A-Award | 1.59 | 2023-06-20 |
| White Lale | director | 2023-06-15 | A-Award | 1.59 | 2023-06-20 |
| PACE GARY W | director | 2023-06-15 | A-Award | 1.59 | 2023-06-20 |
| Mohindru Mani | director | 2023-06-15 | A-Award | 1.59 | 2023-06-20 |
| TANNENBAUM RENEE P | director | 2023-06-15 | A-Award | 1.59 | 2023-06-20 |
| Smeal Tod | officer: Chief Scientific Officer | 2023-03-15 | A-Award | 1.72 | 2023-03-16 |
| Levine James E. | officer: Chief Financial Officer | 2023-03-15 | A-Award | 1.72 | 2023-03-16 |
| Kelemen Vicki | officer: Exec. VP and COO | 2023-03-15 | A-Award | 1.72 | 2023-03-16 |
| Erlander Mark | director, officer: Chief Executive Officer | 2023-03-15 | A-Award | 1.72 | 2023-03-16 |
| Kabbinavar Fairooz | officer: Chief Medical Officer | 2023-01-30 | 1.75 | 2023-02-09 | |
| Erlander Mark | officer: Chief Executive Officer | 2022-11-25 | P-Purchase | 1.43 | 2022-11-29 |
| Armitage James O | director | 2022-09-16 | P-Purchase | 1.5564 | 2022-10-11 |
| White Lale | director | 2022-09-19 | P-Purchase | 1.635 | 2022-09-20 |
| TANNENBAUM RENEE P | director | 2022-09-15 | P-Purchase | 1.72 | 2022-09-19 |
| TANNENBAUM RENEE P | director | 2022-09-15 | P-Purchase | 1.715 | 2022-09-19 |
| PACE GARY W | director | 2022-09-15 | P-Purchase | 1.71 | 2022-09-19 |
| Levine James E. | officer: Chief Financial Officer | 2022-09-16 | P-Purchase | 1.557 | 2022-09-19 |
| White Lale | director: | 2022-07-05 | M-Exempt | 2.6 | 2022-07-06 |
| BRANCACCIO JOHN P | other: Former Director | 2022-06-09 | J-Other | 51.84 | 2022-06-09 |
| BRANCACCIO JOHN P | other: Former Director | 2022-06-09 | J-Other | 372.96 | 2022-06-09 |
| BRANCACCIO JOHN P | other: Former Director | 2022-06-09 | J-Other | 516.96 | 2022-06-09 |
| BRANCACCIO JOHN P | other: Former Director | 2022-06-09 | J-Other | 7.98 | 2022-06-09 |
| BRANCACCIO JOHN P | other: Former Director | 2022-06-09 | J-Other | 316.08 | 2022-06-09 |
| BRANCACCIO JOHN P | other: Former Director | 2022-06-09 | J-Other | 2.48 | 2022-06-09 |
| BRANCACCIO JOHN P | other: Former Director | 2022-06-09 | J-Other | 2.6 | 2022-06-09 |
| BRANCACCIO JOHN P | other: Former Director | 2022-06-09 | J-Other | 21.6 | 2022-06-09 |
| BRANCACCIO JOHN P | other: Former Director | 2022-06-09 | J-Other | 2.5 | 2022-06-09 |
| BRANCACCIO JOHN P | director: | 2022-06-09 | J-Other | 0 | 2022-06-09 |
| PACE GARY W | director: | 2022-03-09 | A-Award | 0 | 2022-03-11 |
| PACE GARY W | director | 2022-03-09 | A-Award | 2.5 | 2022-03-11 |
| White Lale | director: | 2022-03-09 | A-Award | 0 | 2022-03-10 |
| TANNENBAUM RENEE P | director | 2022-03-09 | A-Award | 2.5 | 2022-03-10 |
| TANNENBAUM RENEE P | director: | 2022-03-09 | A-Award | 0 | 2022-03-10 |
| Ruffner Katherine L | officer: Chief Medical Officer | 2022-03-09 | A-Award | 0 | 2022-03-10 |
| Mohindru Mani | director: | 2022-03-09 | A-Award | 0 | 2022-03-10 |
| Mohindru Mani | director | 2022-03-09 | A-Award | 2.5 | 2022-03-10 |
| Markin Rodney S | director: | 2022-03-09 | A-Award | 0 | 2022-03-10 |
| Markin Rodney S | director | 2022-03-09 | A-Award | 2.5 | 2022-03-10 |
| Levine James E. | officer: Chief Financial Officer | 2022-03-09 | A-Award | 0 | 2022-03-10 |
| Kelemen Vicki | officer: Exec. VP and COO | 2022-03-09 | A-Award | 0 | 2022-03-10 |